Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetics of Brugada syndrome.
|
27761167 |
2016 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Local and global interpretations of a disease-causing mutation near the ligand entry path in hyperpolarization-activated cAMP-gated channel.
|
23103389 |
2012 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews.
|
20662977 |
2010 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia.
|
17646576 |
2007 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel.
|
16407510 |
2006 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.
|
15123648 |
2004 |
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Sick Sinus Syndrome 2, Autosomal Dominant
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Brugada Syndrome 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetics of Brugada syndrome.
|
27761167 |
2016 |
Brugada Syndrome 8
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
HCN4 mutation as a molecular explanation on patients with bradycardia and non-compaction cardiomyopathy.
|
26206080 |
2015 |
Brugada Syndrome 8
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy.
|
25145517 |
2014 |
Brugada Syndrome 8
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel.
|
25145518 |
2014 |
Brugada Syndrome 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia.
|
17646576 |
2007 |
Brugada Syndrome 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Brugada Syndrome 8
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 Mutations.
|
27173043 |
2016 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
CLINGEN |
HCN4 dynamically marks the first heart field and conduction system precursors.
|
23743334 |
2013 |
Familial thoracic aortic aneurysm and aortic dissection
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Atrial Fibrillation
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
Together with the common KCNE1 variant S38G, previously proposed as a genetic modifier of AF, HCN4-P883R may provide a substrate for the development of AF and TIC.
|
31481236 |
2019 |
Atrial Fibrillation
|
0.490 |
Biomarker
|
disease |
BEFREE |
In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of I<sub>f</sub> inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.
|
30606942 |
2019 |
Atrial Fibrillation
|
0.490 |
Biomarker
|
disease |
CTD_human |
Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.
|
30061737 |
2018 |
Atrial Fibrillation
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation (43.5 ± 22.1 years) than were SCN5A mutation carriers (17.8 ± 16.5 years; P <.001).
|
28104484 |
2017 |
Atrial Fibrillation
|
0.490 |
GeneticVariation
|
disease |
BEFREE |
One interaction, between rs7164883 at the HCN4 locus and rs4980345 at the SLC28A1 locus, was found to be significantly associated with AF in the discovery cohorts (interaction OR = 1.44, 95% CI: 1.27-1.65, P = 4.3 × 10<sup>-8</sup>).
|
27824142 |
2016 |
Atrial Fibrillation
|
0.490 |
Biomarker
|
disease |
BEFREE |
Together with the findings that caveolin-1 interacts with potassium channels Kir2.1, KCNH2, and HCN4 and sodium channels Nav1.5 and Nav1.8, CAV1 becomes a strong candidate susceptibility gene for AF across different ethnic populations.
|
25953654 |
2015 |